Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
CXCR4 is a cytokine receptor used by HIV during cell attachment and infection. Overexpressed in the cancer stem cells of more than 20 human neoplasias, CXCR4 is a convenient antitumoral drug target. T22 is a polyphemusin-derived peptide and an effective CXCR4 ligand. Its highly selective CXCR4 bindi...
Guardado en:
Autores principales: | Naroa Serna, José Vicente Carratalá, Oscar Conchillo-Solé, Carlos Martínez-Torró, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Xavier Daura, Esther Vázquez, Antonio Villaverde |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ce775b1fd7147279d540e20658bd677 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta U, et al.
Publicado: (2012) -
Actividad inhibitoria del sobrenadante de la bacteria Antártica Pseudomonas sp. M19B en la formación de biopelículas de Flavobacterium psychrophilum 19749
por: Leyton,Arely, et al.
Publicado: (2015) -
Bacitracin-Ag Nanoclusters as a Novel Antibacterial Agent Combats <i>Shigella flexneri</i> by Disrupting Cell Membrane and Inhibiting Biofilm Formation
por: Lin Wang, et al.
Publicado: (2021) -
Majorization for certain classes of analytic functions defined by a new operator
por: Eljamal,E. A, et al.
Publicado: (2012) -
Broad and Effective Protection against <named-content content-type="genus-species">Staphylococcus aureus</named-content> Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens
por: Jian Deng, et al.
Publicado: (2019)